Compounds > 5-hydroxy-3',4',6,7-tetramethoxyflavone
Page last updated: 2024-09-04

5-hydroxy-3',4',6,7-tetramethoxyflavone and salvigenin

5-hydroxy-3',4',6,7-tetramethoxyflavone has been researched along with salvigenin in 1 studies

Compound Research Comparison

Studies
(5-hydroxy-3',4',6,7-tetramethoxyflavone)		Trials
(5-hydroxy-3',4',6,7-tetramethoxyflavone)		Recent Studies (post-2010)
(5-hydroxy-3',4',6,7-tetramethoxyflavone)		Studies
(salvigenin)		Trials
(salvigenin)		Recent Studies (post-2010) (salvigenin)
150727019

Protein Interaction Comparison

ProteinTaxonomy5-hydroxy-3',4',6,7-tetramethoxyflavone (IC50)salvigenin (IC50)
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.4733

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutler, SJ; Elokely, KM; Klein, ML; Lambert, J; León, F; Mansoor, A; Pettaway, S; Tarawneh, A1

Other Studies

1 other study(ies) available for 5-hydroxy-3',4',6,7-tetramethoxyflavone and salvigenin

ArticleYear
Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid Receptors.
    Journal of natural products, 2015, Jun-26, Volume: 78, Issue:6

    Topics: Flavones; Flavonoids; Humans; In Vitro Techniques; Lamiaceae; Ligands; Molecular Structure; Pakistan; Plant Leaves; Receptors, Cannabinoid; Receptors, Opioid, delta

2015